Home > Request Information
Title:
Abivax Announces German Regulatory Approval of ABX464 Covid-19 Phase 2b/3 COVID-19 Clinical Trial
* Company:
* Country:
* Name:
Job Title:
* Tel:
Fax:
* E-mail:
Message:
Verification Code:
refresh